Sigma Planning Corp Has $425,000 Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Sigma Planning Corp cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 46.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,128 shares of the financial services provider’s stock after selling 2,707 shares during the period. Sigma Planning Corp’s holdings in iShares Biotechnology ETF were worth $425,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Glass Jacobson Investment Advisors llc grew its stake in shares of iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after buying an additional 122 shares in the last quarter. Values First Advisors Inc. bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $43,000. Horizon Bancorp Inc. IN bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at $44,000. Tennessee Valley Asset Management Partners bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $44,000. Finally, Column Capital Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at $49,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $126.49 on Friday. The firm has a fifty day simple moving average of $134.45 and a 200 day simple moving average of $129.71. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.